Search

everythinglearnresearchcommunity

for

Search:↓

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Using both PRP and minoxidil together works better for treating hair loss in men than using either one alone.

Possible link between COVID-19 and hair loss; more research needed.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Analog 23 is a promising compound for prostate cancer treatment.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Dieckol from Ecklonia cava may help hair growth and could be a potential hair loss treatment.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Hair restoration surgery can lead to swelling, infections, scarring, numbness, hiccups, and poor hair growth.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

The document concludes that injecting platelet-rich plasma can effectively treat androgenetic alopecia, a type of hair loss.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Compounds from the plant Mammea siamensis may help treat hair loss.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Androgens in female meerkats influence aggression and dominance, affecting social dynamics and offspring behavior.